Search Results 61-70 of 16982 for Hepatic flexure
Learn what to expect before and after this important treatment option for people with liver failure.
In this Q&A, Kirk J. Wangensteen, M.D., Ph.D., explains how researchers are using CRISPR/Cas9 to study and develop new therapies for human liver diseases.
Potentially Resectable Pancreatic Cancer - No involvement of the celiac artery, common hepatic artery, and superior mesenteric artery (SMA) and, if present, ...
Learn how a multispecialty group of experts can help you with the diagnosis and treatment of pulmonary complications of liver disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.